Drug intelligence / Profile preview

ProImmune Immune Formulation 200

Development stage
Phase 1
Lead developer
ProImmune
Administration
Oral
01

Overview

ProImmune Immune Formulation 200 is a patented dietary supplement designed to support immune health and overall wellness by promoting the body's natural production of glutathione, a key intracellular antioxidant. Developed by Dr. Albert B. Crum, this formulation utilizes L-cystine as an optimal carrier for L-cysteine into cells, facilitating efficient glutathione synthesis even under oxidative stress conditions. The product activates the Nrf2 gene pathway to enhance endogenous antioxidant enzyme production and supports detoxification processes at the cellular level. It is marketed for its potential benefits in immune defense, reduction of oxidative stress, tissue repair and regeneration, cognitive function optimization, cardiovascular health support through cholesterol processing assistance, skin health via collagen protection from oxidative damage, energy production enhancement at the cellular level, and liver function support through detoxification[1][2][5][8][9]. The supplement has been recognized for its stability under various environmental conditions and can be used as an ingredient in food products[9]. Peer-reviewed research has documented its antiviral properties and broader applications in human health[1].

Brand names
ProImmune 200ProImmune200ProImmune-200Immune Formulation 200ProImmune
Other names
ProImmune Immune Formulation 200IF-200IF200IF 200
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on ProImmune Immune Formulation 200.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProImmune Immune Formulation 200.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call